A gel-like sugar coating on immune cells has been found to play a starring role in psoriasis. Researchers discovered that immune cells shed this outer layer to help them exit the bloodstream and enter ...

Maintenance therapy with subcutaneous imsidolimab allowed all treated patients to remain flare-free throughout the GEMINI-2 study period.

Why aren't we talking about it more?

Feb 18 (Reuters) - Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

Patients with psoriasis were associated with significantly lower circulating BDNF levels compared with healthy control individuals.

An increase in the proportion of plant-based foods in the diet may be associated with a decrease in the severity of psoriasis symptoms. This conclusion was reached by researchers from King's College ...

Oruka Therapeutics, Inc. has surged after ORKA-001 showed a half-life four times that of Skyrizi in Phase 1, targeting the ...

Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...

Evidence from multiple trials links weight loss with milder symptoms and improved wellbeing in people with psoriasis.

Portia has not taken Sotyktu. Portia Brown* has long been drawn toward helping people cope with challenges. Since volunteering as a college student to work with her peers to educate them about sexual ...